Senators Urge FDA to Reduce Regulatory Barriers for Insulin

Drug Industry Daily
A A
A bipartisan group of senators asked FDA Commissioner Scott Gottlieb to expedite the approval process for new insulin products.

To View This Article:

Login

Subscribe To Drug Industry Daily